WTW Stock Forecast & Price Target

Willis Towers Watson is expected to continue driving margin expansion through cost reduction and top-line growth through cross-selling, with a potential shift towards insurance brokerage, especially in the health segment. The implementation of AI initiatives, such as Propel, is expected to improve efficiency and contribute to higher margins. Risks to this positive outlook include a decline in insurance pricing and economic conditions, as well as poorly executed M&A. In the second quarter of 2026, the company reported adjusted EBITDA of $529 million, up 13% from the same period in 2025, and a cash flow from operations of $474 million, driven by operating margin expansion. Further margin expansion is anticipated through AI automation, which will enable producers to pursue more revenue. The company also has a strong track record for share repurchases and a new investment initiative, Propel, is expected to generate significant cost savings and contribute to a 30% adjusted operating margin in 2028.

Willis Towers Watson is facing a decline in insurable risks and facing economic uncertainty which could negatively impact their core lines of business. Their AI program is expected to improve efficiency, but revenue growth may be offset by a higher share count. While their current outlook appears positive, any further deterioration of the economy could impact the company's growth and margin expansion plans.